Atlas Trials

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Clinical trial NCT00002947 · TERMINATED

Trial details

NCT number
NCT00002947
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid TumorHead and Neck CancerIntraocular MelanomaIslet Cell TumorKidney CancerLung CancerMelanoma (Skin)Neoplastic SyndromeNeuroendocrine Carcinoma of the SkinPheochromocytoma
Start date
1996-10-01
Primary completion
2004-08-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.